<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1992-12-01" modified="2020-10-07" version="218">
<accession>Q00403</accession>
<accession>A8K1A7</accession>
<accession>Q5JS30</accession>
<name>TF2B_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="56">Transcription initiation factor IIB</fullName>
<ecNumber evidence="27">2.3.1.48</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="57">General transcription factor TFIIB</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="55">S300-II</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">GTF2B</name>
<name type="synonym">TF2B</name>
<name type="synonym">TFIIB</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1991" name="Nature" volume="352" first="689" last="695">
<title>Cloning of a human gene encoding the general transcription initiation factor IIB.</title>
<authorList>
<person name="Ha I."/>
<person name="Lane W.S."/>
<person name="Reinberg D."/>
</authorList>
<dbReference type="PubMed" id="1876184"/>
<dbReference type="DOI" id="10.1038/352689a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>ASSOCIATION WITH THE TFIID-TFIIA COMPLEX</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1991" name="Proc. Natl. Acad. Sci. U.S.A." volume="88" first="9553" last="9557">
<title>Sequence of general transcription factor TFIIB and relationships to other initiation factors.</title>
<authorList>
<person name="Malik S."/>
<person name="Hisatake K."/>
<person name="Sumimoto H."/>
<person name="Horikoshi M."/>
<person name="Roeder R.G."/>
</authorList>
<dbReference type="PubMed" id="1946368"/>
<dbReference type="DOI" id="10.1073/pnas.88.21.9553"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2008" name="Nat. Methods" volume="5" first="1011" last="1017">
<title>Human protein factory for converting the transcriptome into an in vitro-expressed proteome.</title>
<authorList>
<person name="Goshima N."/>
<person name="Kawamura Y."/>
<person name="Fukumoto A."/>
<person name="Miura A."/>
<person name="Honma R."/>
<person name="Satoh R."/>
<person name="Wakamatsu A."/>
<person name="Yamamoto J."/>
<person name="Kimura K."/>
<person name="Nishikawa T."/>
<person name="Andoh T."/>
<person name="Iida Y."/>
<person name="Ishikawa K."/>
<person name="Ito E."/>
<person name="Kagawa N."/>
<person name="Kaminaga C."/>
<person name="Kanehori K."/>
<person name="Kawakami B."/>
<person name="Kenmochi K."/>
<person name="Kimura R."/>
<person name="Kobayashi M."/>
<person name="Kuroita T."/>
<person name="Kuwayama H."/>
<person name="Maruyama Y."/>
<person name="Matsuo K."/>
<person name="Minami K."/>
<person name="Mitsubori M."/>
<person name="Mori M."/>
<person name="Morishita R."/>
<person name="Murase A."/>
<person name="Nishikawa A."/>
<person name="Nishikawa S."/>
<person name="Okamoto T."/>
<person name="Sakagami N."/>
<person name="Sakamoto Y."/>
<person name="Sasaki Y."/>
<person name="Seki T."/>
<person name="Sono S."/>
<person name="Sugiyama A."/>
<person name="Sumiya T."/>
<person name="Takayama T."/>
<person name="Takayama Y."/>
<person name="Takeda H."/>
<person name="Togashi T."/>
<person name="Yahata K."/>
<person name="Yamada H."/>
<person name="Yanagisawa Y."/>
<person name="Endo Y."/>
<person name="Imamoto F."/>
<person name="Kisu Y."/>
<person name="Tanaka S."/>
<person name="Isogai T."/>
<person name="Imai J."/>
<person name="Watanabe S."/>
<person name="Nomura N."/>
</authorList>
<dbReference type="PubMed" id="19054851"/>
<dbReference type="DOI" id="10.1038/nmeth.1273"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Prostate</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1992" name="J. Biol. Chem." volume="267" first="17617" last="17623">
<title>Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II).</title>
<authorList>
<person name="Ing N.H."/>
<person name="Beekman J.M."/>
<person name="Tsai S.Y."/>
<person name="Tsai M.J."/>
<person name="O'Malley B.W."/>
</authorList>
<dbReference type="PubMed" id="1517211"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 6-316</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ESR1; NR2F1 AND PGR</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1987" name="J. Biol. Chem." volume="262" first="3322" last="3330">
<title>Factors involved in specific transcription in mammalian RNA polymerase II. Functional analysis of initiation factors IIA and IID and identification of a new factor operating at sequences downstream of the initiation site.</title>
<authorList>
<person name="Reinberg D."/>
<person name="Horikoshi M."/>
<person name="Roeder R.G."/>
</authorList>
<dbReference type="PubMed" id="3818643"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN A RNA POLYMERASE II INITIATION COMPLEX</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1987" name="J. Biol. Chem." volume="262" first="3310" last="3321">
<title>Factors involved in specific transcription by mammalian RNA polymerase II. Purification and functional analysis of initiation factors IIB and IIE.</title>
<authorList>
<person name="Reinberg D."/>
<person name="Roeder R.G."/>
</authorList>
<dbReference type="PubMed" id="3029109"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN A RNA POLYMERASE II INITIATION COMPLEX</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1990" name="Mol. Cell. Biol." volume="10" first="6335" last="6347">
<title>Factors involved in specific transcription by mammalian RNA polymerase II: role of transcription factors IIA, IID, and IIB during formation of a transcription-competent complex.</title>
<authorList>
<person name="Maldonado E."/>
<person name="Ha I."/>
<person name="Cortes P."/>
<person name="Weis L."/>
<person name="Reinberg D."/>
</authorList>
<dbReference type="PubMed" id="2247058"/>
<dbReference type="DOI" id="10.1128/mcb.10.12.6335"/>
</citation>
<scope>ASSOCIATION WITH THE TFIID-TFIIA COMPLEX</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1993" name="Genes Dev." volume="7" first="1021" last="1032">
<title>Multiple functional domains of human transcription factor IIB: distinct interactions with two general transcription factors and RNA polymerase II.</title>
<authorList>
<person name="Ha I."/>
<person name="Roberts S."/>
<person name="Maldonado E."/>
<person name="Sun X."/>
<person name="Kim L.U."/>
<person name="Green M."/>
<person name="Reinberg D."/>
</authorList>
<dbReference type="PubMed" id="8504927"/>
<dbReference type="DOI" id="10.1101/gad.7.6.1021"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH GTF2F2; RNA POLYMERASE II AND TBP</scope>
<scope>MUTAGENESIS OF ARG-286; ARG-290 AND ARG-295</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1993" name="J. Virol." volume="67" first="4676" last="4687">
<title>ICP4, the major transcriptional regulatory protein of herpes simplex virus type 1, forms a tripartite complex with TATA-binding protein and TFIIB.</title>
<authorList>
<person name="Smith C.A."/>
<person name="Bates P."/>
<person name="Rivera-Gonzalez R."/>
<person name="Gu B."/>
<person name="DeLuca N.A."/>
</authorList>
<dbReference type="PubMed" id="8392607"/>
</citation>
<scope>INTERACTION WITH HERPES SIMPLEX VIRUS 1 ICP4 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1993" name="Mol. Cell. Biol." volume="13" first="6253" last="6259">
<title>Potential RNA polymerase II-induced interactions of transcription factor TFIIB.</title>
<authorList>
<person name="Malik S."/>
<person name="Lee D.K."/>
<person name="Roeder R.G."/>
</authorList>
<dbReference type="PubMed" id="8413225"/>
<dbReference type="DOI" id="10.1128/mcb.13.10.6253"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN A RNA POLYMERASE II INITIATION COMPLEX</scope>
<scope>INTERACTION WITH RNA POLYMERASE II</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1993" name="Nature" volume="363" first="741" last="744">
<title>Interaction between an acidic activator and transcription factor TFIIB is required for transcriptional activation.</title>
<authorList>
<person name="Roberts S.G."/>
<person name="Ha I."/>
<person name="Maldonado E."/>
<person name="Reinberg D."/>
<person name="Green M.R."/>
</authorList>
<dbReference type="PubMed" id="8515819"/>
<dbReference type="DOI" id="10.1038/363741a0"/>
</citation>
<scope>INTERACTION WITH HERPES VIRUS ACTIVATOR PROTEIN VP16 (MICROBIAL INFECTION)</scope>
<scope>MUTAGENESIS OF ARG-185; LYS-189; ARG-193; LYS-196 AND LYS-200</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1993" name="Nature" volume="363" first="744" last="747">
<title>Functional dissection of TFIIB domains required for TFIIB-TFIID-promoter complex formation and basal transcription activity.</title>
<authorList>
<person name="Hisatake K."/>
<person name="Roeder R.G."/>
<person name="Horikoshi M."/>
</authorList>
<dbReference type="PubMed" id="8515820"/>
<dbReference type="DOI" id="10.1038/363744a08316289"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH TATA BOX-BOUND TBP</scope>
<scope>DOMAINS</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1993" name="Proc. Natl. Acad. Sci. U.S.A." volume="90" first="5628" last="5632">
<title>Delineation of two functional regions of transcription factor TFIIB.</title>
<authorList>
<person name="Barberis A."/>
<person name="Mueller C.W."/>
<person name="Harrison S.C."/>
<person name="Ptashne M."/>
</authorList>
<dbReference type="PubMed" id="8516311"/>
<dbReference type="DOI" id="10.1073/pnas.90.12.5628"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH TATA BOX-BOUND TBP</scope>
<scope>DOMAINS</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1993" name="Proc. Natl. Acad. Sci. U.S.A." volume="90" first="5633" last="5637">
<title>Functional domains of transcription factor TFIIB.</title>
<authorList>
<person name="Buratowski S."/>
<person name="Zhou H."/>
</authorList>
<dbReference type="PubMed" id="8516312"/>
<dbReference type="DOI" id="10.1073/pnas.90.12.5633"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN A RNA POLYMERASE II INITIATION COMPLEX</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF CYS-37 AND GLY-247</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1995" name="Gene" volume="167" first="297" last="302">
<title>Isolation and characterization of a cDNA encoding a new type of human transcription elongation factor S-II.</title>
<authorList>
<person name="Umehara T."/>
<person name="Kida S."/>
<person name="Yamamoto T."/>
<person name="Horikoshi M."/>
</authorList>
<dbReference type="PubMed" id="8566795"/>
<dbReference type="DOI" id="10.1016/0378-1119(95)00634-6"/>
</citation>
<scope>INTERACTION WITH TCEA2</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1995" name="Genes Dev." volume="9" first="1479" last="1490">
<title>Recycling of the general transcription factors during RNA polymerase II transcription.</title>
<authorList>
<person name="Zawel L."/>
<person name="Kumar K.P."/>
<person name="Reinberg D."/>
</authorList>
<dbReference type="PubMed" id="7601352"/>
<dbReference type="DOI" id="10.1101/gad.9.12.1479"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN A RNA POLYMERASE II INITIATION COMPLEX</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1995" name="J. Virol." volume="69" first="585" last="588">
<title>The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein.</title>
<authorList>
<person name="Tong X."/>
<person name="Wang F."/>
<person name="Thut C.J."/>
<person name="Kieff E."/>
</authorList>
<dbReference type="PubMed" id="7983760"/>
</citation>
<scope>INTERACTION WITH EBV EBNA2 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="11703" last="11709">
<title>RNA polymerase II-associated protein (RAP) 74 binds transcription factor (TF) IIB and blocks TFIIB-RAP30 binding.</title>
<authorList>
<person name="Fang S.M."/>
<person name="Burton Z.F."/>
</authorList>
<dbReference type="PubMed" id="8662660"/>
<dbReference type="DOI" id="10.1074/jbc.271.20.11703"/>
</citation>
<scope>INTERACTION WITH GTF2F1 AND GTF2F2</scope>
<scope>REGION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1996" name="J. Mol. Biol." volume="261" first="599" last="606">
<title>The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB.</title>
<authorList>
<person name="Agostini I."/>
<person name="Navarro J.-M."/>
<person name="Rey F."/>
<person name="Bouhamdan M."/>
<person name="Spire B."/>
<person name="Vigne R."/>
<person name="Sire J."/>
</authorList>
<dbReference type="PubMed" id="8800208"/>
<dbReference type="DOI" id="10.1006/jmbi.1996.0485"/>
</citation>
<scope>INTERACTION WITH HIV-1 VPR (MICROBIAL INFECTION)</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1998" name="Genes Dev." volume="12" first="34" last="44">
<title>New core promoter element in RNA polymerase II-dependent transcription: sequence-specific DNA binding by transcription factor IIB.</title>
<authorList>
<person name="Lagrange T."/>
<person name="Kapanidis A.N."/>
<person name="Tang H."/>
<person name="Reinberg D."/>
<person name="Ebright R.H."/>
</authorList>
<dbReference type="PubMed" id="9420329"/>
<dbReference type="DOI" id="10.1101/gad.12.1.34"/>
</citation>
<scope>FUNCTION</scope>
<scope>DNA-BINDING</scope>
<scope>MUTAGENESIS OF VAL-283 AND ARG-286</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1999" name="FEBS Lett." volume="450" first="235" last="239">
<title>The HIV-1 Vpr co-activator induces a conformational change in TFIIB.</title>
<authorList>
<person name="Agostini I."/>
<person name="Navarro J.M."/>
<person name="Bouhamdan M."/>
<person name="Willetts K."/>
<person name="Rey F."/>
<person name="Spire B."/>
<person name="Vigne R."/>
<person name="Pomerantz R."/>
<person name="Sire J."/>
</authorList>
<dbReference type="PubMed" id="10359081"/>
<dbReference type="DOI" id="10.1016/s0014-5793(99)00501-3"/>
</citation>
<scope>MUTAGENESIS OF 52-GLU--SER-56</scope>
</reference>
<reference key="25">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="14337" last="14343">
<title>The role of human TFIIB in transcription start site selection in vitro and in vivo.</title>
<authorList>
<person name="Hawkes N.A."/>
<person name="Roberts S.G."/>
</authorList>
<dbReference type="PubMed" id="10318856"/>
<dbReference type="DOI" id="10.1074/jbc.274.20.14337"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF GLU-51 AND ARG-66</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2000" name="Cell Stress Chaperones" volume="5" first="229" last="242">
<title>Potential targets for HSF1 within the preinitiation complex.</title>
<authorList>
<person name="Yuan C.X."/>
<person name="Gurley W.B."/>
</authorList>
<dbReference type="PubMed" id="11005381"/>
<dbReference type="DOI" id="10.1379/1466-1268(2000)005&lt;0229:ptfhwt&gt;2.0.co;2"/>
</citation>
<scope>INTERACTION WITH HSF1</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2003" name="Nature" volume="424" first="965" last="969">
<title>Transcription factor IIB acetylates itself to regulate transcription.</title>
<authorList>
<person name="Choi C.H."/>
<person name="Hiromura M."/>
<person name="Usheva A."/>
</authorList>
<dbReference type="PubMed" id="12931194"/>
<dbReference type="DOI" id="10.1038/nature01899"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACETYLATION AT LYS-238</scope>
<scope>AUTOACETYLATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>INTERACTION WITH GTF2F1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-238</scope>
<scope>CHROMATIN-BINDING</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2005" name="Genes Dev." volume="19" first="2418" last="2423">
<title>A core promoter element downstream of the TATA box that is recognized by TFIIB.</title>
<authorList>
<person name="Deng W."/>
<person name="Roberts S.G."/>
</authorList>
<dbReference type="PubMed" id="16230532"/>
<dbReference type="DOI" id="10.1101/gad.342405"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF GLY-153</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="31">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70; SER-76 AND SER-92</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2014" name="Sci. Rep." volume="4" first="3664" last="3664">
<title>A new paradigm for transcription factor TFIIB functionality.</title>
<authorList>
<person name="Gelev V."/>
<person name="Zabolotny J.M."/>
<person name="Lange M."/>
<person name="Hiromura M."/>
<person name="Yoo S.W."/>
<person name="Orlando J.S."/>
<person name="Kushnir A."/>
<person name="Horikoshi N."/>
<person name="Paquet E."/>
<person name="Bachvarov D."/>
<person name="Schaffer P.A."/>
<person name="Usheva A."/>
</authorList>
<dbReference type="PubMed" id="24441171"/>
<dbReference type="DOI" id="10.1038/srep03664"/>
</citation>
<scope>FUNCTION</scope>
<scope>FUNCTION IN HSV-1 TRANSCRIPTION AND REPLICATION (MICROBIAL INFECTION)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHROMATIN-BINDING</scope>
<scope>ACETYLATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="34">
<citation type="journal article" date="1995" name="Cell" volume="82" first="857" last="867">
<title>Solution structure of the C-terminal core domain of human TFIIB: similarity to cyclin A and interaction with TATA-binding protein.</title>
<authorList>
<person name="Bagby S."/>
<person name="Kim S."/>
<person name="Maldonado E."/>
<person name="Tong K.I."/>
<person name="Reinberg D."/>
<person name="Ikura M."/>
</authorList>
<dbReference type="PubMed" id="7671313"/>
<dbReference type="DOI" id="10.1016/0092-8674(95)90483-2"/>
</citation>
<scope>STRUCTURE BY NMR OF 111-316</scope>
</reference>
<reference key="35" evidence="6">
<citation type="journal article" date="1995" name="Nature" volume="377" first="119" last="128">
<title>Crystal structure of a TFIIB-TBP-TATA-element ternary complex.</title>
<authorList>
<person name="Nikolov D.B."/>
<person name="Chen H."/>
<person name="Halay E.D."/>
<person name="Usheva A.A."/>
<person name="Hisatake K."/>
<person name="Lee D.K."/>
<person name="Roeder R.G."/>
<person name="Burley S.K."/>
</authorList>
<dbReference type="PubMed" id="7675079"/>
<dbReference type="DOI" id="10.1038/377119a0"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 113-316 IN COMPLEX WITH PLANT TATA BOX-BINDING PROTEIN AND DNA</scope>
<scope>DNA-BINDING</scope>
</reference>
<reference key="36" evidence="5">
<citation type="journal article" date="1998" name="Biochemistry" volume="37" first="7941" last="7951">
<title>Human general transcription factor TFIIB: conformational variability and interaction with VP16 activation domain.</title>
<authorList>
<person name="Hayashi F."/>
<person name="Ishima R."/>
<person name="Liu D."/>
<person name="Tong K.I."/>
<person name="Kim S."/>
<person name="Reinberg D."/>
<person name="Bagby S."/>
<person name="Ikura M."/>
</authorList>
<dbReference type="PubMed" id="9609687"/>
<dbReference type="DOI" id="10.1021/bi9801098"/>
</citation>
<scope>STRUCTURE BY NMR OF 112-316</scope>
</reference>
<reference key="37" evidence="1">
<citation type="journal article" date="2000" name="EMBO J." volume="19" first="25" last="36">
<title>Structural basis of preinitiation complex assembly on human pol II promoters.</title>
<authorList>
<person name="Tsai F.T.F."/>
<person name="Sigler P.B."/>
</authorList>
<dbReference type="PubMed" id="10619841"/>
<dbReference type="DOI" id="10.1093/emboj/19.1.25"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) OF 110-316 IN COMPLEX WITH TBP AND DNA</scope>
<scope>INTERACTION WITH TBP</scope>
<scope>DNA-BINDING</scope>
</reference>
<reference key="38" evidence="2">
<citation type="journal article" date="2000" name="Protein Sci." volume="9" first="1743" last="1752">
<title>Structure of a (Cys3His) zinc ribbon, a ubiquitous motif in archaeal and eucaryal transcription.</title>
<authorList>
<person name="Chen H.T."/>
<person name="Legault P."/>
<person name="Glushka J."/>
<person name="Omichinski J.G."/>
<person name="Scott R.A."/>
</authorList>
<dbReference type="PubMed" id="11045620"/>
<dbReference type="DOI" id="10.1110/ps.9.9.1743"/>
</citation>
<scope>STRUCTURE BY NMR OF 2-59 IN COMPLEX WITH ZINC</scope>
</reference>
<reference key="39" evidence="3 4">
<citation type="journal article" date="2004" name="Biochem. J." volume="378" first="317" last="324">
<title>Probing Zn2+-binding effects on the zinc-ribbon domain of human general transcription factor TFIIB.</title>
<authorList>
<person name="Ghosh M."/>
<person name="Elsby L.M."/>
<person name="Mal T.K."/>
<person name="Gooding J.M."/>
<person name="Roberts S.G."/>
<person name="Ikura M."/>
</authorList>
<dbReference type="PubMed" id="14641108"/>
<dbReference type="DOI" id="10.1042/bj20031706"/>
</citation>
<scope>STRUCTURE BY NMR OF 1-60 IN APO AND -BOUND FORMS IN COMPLEX WITH ZINC</scope>
</reference>
<reference key="40" evidence="7">
<citation type="journal article" date="2005" name="Biochemistry" volume="44" first="827" last="839">
<title>Structural properties of the promiscuous VP16 activation domain.</title>
<authorList>
<person name="Jonker H.R."/>
<person name="Wechselberger R.W."/>
<person name="Boelens R."/>
<person name="Folkers G.E."/>
<person name="Kaptein R."/>
</authorList>
<dbReference type="PubMed" id="15654739"/>
<dbReference type="DOI" id="10.1021/bi0482912"/>
</citation>
<scope>STRUCTURE BY NMR OF 111-316 IN COMPLEX WITH HERPES VIRUS ACTIVATOR PROTEIN VP16</scope>
<scope>INTERACTION WITH VP16 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="41" evidence="8 9 10 11 12 13 14 15">
<citation type="journal article" date="2016" name="Nature" volume="533" first="359" last="365">
<title>Near-atomic resolution visualization of human transcription promoter opening.</title>
<authorList>
<person name="He Y."/>
<person name="Yan C."/>
<person name="Fang J."/>
<person name="Inouye C."/>
<person name="Tjian R."/>
<person name="Ivanov I."/>
<person name="Nogales E."/>
</authorList>
<dbReference type="PubMed" id="27193682"/>
<dbReference type="DOI" id="10.1038/nature17970"/>
</citation>
<scope>STRUCTURE BY ELECTRON MICROSCOPY (3.90 ANGSTROMS)</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="42" evidence="16">
<citation type="journal article" date="2018" name="J. Biol. Chem." volume="293" first="1651" last="1665">
<title>Structural dissection of an interaction between transcription initiation and termination factors implicated in promoter-terminator cross-talk.</title>
<authorList>
<person name="Bratkowski M."/>
<person name="Unarta I.C."/>
<person name="Zhu L."/>
<person name="Shubbar M."/>
<person name="Huang X."/>
<person name="Liu X."/>
</authorList>
<dbReference type="PubMed" id="29158257"/>
<dbReference type="DOI" id="10.1074/jbc.m117.811521"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.39 ANGSTROMS) OF 107-316 OF APOPROTEIN</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH TATA BOX-BOUND TBP</scope>
<scope>INTERACTION WITH SSU72</scope>
<scope>MUTAGENESIS OF ARG-185; LYS-189; ARG-193; 200-LYS--LEU-208; LYS-200 AND LEU-208</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] GLN-132</scope>
</reference>
<comment type="function">
<text evidence="22 24 27 29 31 33 34 36 37 39 40 41 42 45 46 48 49 50 54">General transcription factor that plays a role in transcription initiation by RNA polymerase II (Pol II). Involved in the pre-initiation complex (PIC) formation and Pol II recruitment at promoter DNA (PubMed:1876184, PubMed:1946368, PubMed:1517211, PubMed:3818643, PubMed:3029109, PubMed:8413225, PubMed:8515820, PubMed:8516311, PubMed:8516312, PubMed:7601352, PubMed:9420329, PubMed:12931194, PubMed:27193682). Together with the TATA box-bound TBP forms the core initiation complex and provides a bridge between TBP and the Pol II-TFIIF complex (PubMed:8504927, PubMed:8413225, PubMed:8515820, PubMed:8516311, PubMed:8516312). Released from the PIC early following the onset of transcription during the initiation and elongation transition and reassociates with TBP during the next transcription cycle (PubMed:7601352). Associates with chromatin to core promoter-specific regions (PubMed:12931194, PubMed:24441171). Binds to two distinct DNA core promoter consensus sequence elements in a TBP-independent manner; these IIB-recognition elements (BREs) are localized immediately upstream (BREu), 5'-[GC][GC][GA]CGCC-3', and downstream (BREd), 5'-[GA]T[TGA][TG][GT][TG][TG]-3', of the TATA box element (PubMed:9420329, PubMed:16230532, PubMed:7675079, PubMed:10619841). Modulates transcription start site selection (PubMed:10318856). Exhibits also autoacetyltransferase activity that contributes to the activated transcription (PubMed:12931194).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="27">
<text>acetyl-CoA + L-lysyl-[protein] = CoA + H(+) + N(6)-acetyl-L-lysyl-[protein]</text>
<dbReference type="Rhea" id="RHEA:45948"/>
<dbReference type="Rhea" id="RHEA-COMP:9752"/>
<dbReference type="Rhea" id="RHEA-COMP:10731"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:29969"/>
<dbReference type="ChEBI" id="CHEBI:57287"/>
<dbReference type="ChEBI" id="CHEBI:57288"/>
<dbReference type="ChEBI" id="CHEBI:61930"/>
<dbReference type="EC" id="2.3.1.48"/>
</reaction>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="27">0.117 mM for acetyl-CoA</KM>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="20 24 25 27 29 33 35 37 38 39 40 41 45 46 48 49 50 51 52">Found in a ternary complex with TATA box-bound TBP (PubMed:8413225, PubMed:8515820, PubMed:8516311, PubMed:8516312, PubMed:10619841, PubMed:29158257). Part of a TFIID-containing RNA polymerase II pre-initiation complex (PIC) that is composed of TBP and at least GTF2A1, GTF2A2, GTF2E1, GTF2E2, GTF2F1, GTF2H2, GTF2H3, GTF2H4, GTF2H5, GTF2B, TCEA1, ERCC2, ERCC3, TAF1, TAF2, TAF3, TAF4, TAF5, TAF6, TAF7, TAF8, TAF9, TAF10, TAF11, TAF12 and TAF13 (PubMed:27193682). Associates with TFIID-TFIIA (DA complex) to form TFIID-TFIIA-TFIIB (DAB complex), which is then recognized by RNA polymerase II (Pol II) (PubMed:1876184, PubMed:2247058). Found in a RNA polymerase II initiation complex (PubMed:3818643, PubMed:3029109, PubMed:8413225, PubMed:8516312, PubMed:7601352). Interacts (via C-terminus) with TBP; this interaction with TATA box-bound TBP guides Pol II into the PIC (PubMed:8504927, PubMed:10619841). Interacts (via N-terminus) with Pol II (PubMed:8504927, PubMed:8413225). Interacts (via C-terminus) with SSU72; this interaction is inhibited by SYMPK (PubMed:29158257). Interacts with NR2F1; this interaction is direct (PubMed:1517211). Interacts with PGR (PubMed:1517211). Interacts with ESR1 (PubMed:1517211). Interacts with GTF2F1 (via C-terminus and preferentially via acetylated form); this interaction prevents binding of GTF2B to GTF2F2 (PubMed:8662660, PubMed:12931194). Interacts with GTF2F2 (via N-terminus); this interaction is inhibited in presence of GTF2F1 (PubMed:8504927, PubMed:8662660). Interacts with the transcription elongation factor TCEA2 (PubMed:8566795). Interacts with HSF1 (via transactivation domain) (PubMed:11005381). Interacts with GPBP1 (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="53">(Microbial infection) Interacts with HIV-1 Vpr.</text>
</comment>
<comment type="subunit">
<text evidence="43">(Microbial infection) Interacts with Epstein-Barr virus EBNA2.</text>
</comment>
<comment type="subunit">
<text evidence="44">(Microbial infection) Interacts with Herpes simplex virus 1 protein ICP4.</text>
</comment>
<comment type="subunit">
<text evidence="30 47">(Microbial infection) Interacts (via C-terminus) with the Herpes simplex virus activator VP16; this interaction stimulates RNA Pol II transcription by increasing the extent of pre-initiation complex assembly.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-389564">
<id>Q00403</id>
</interactant>
<interactant intactId="EBI-712941">
<id>Q14919</id>
<label>DRAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-389564">
<id>Q00403</id>
</interactant>
<interactant intactId="EBI-447295">
<id>Q09472</id>
<label>EP300</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-389564">
<id>Q00403</id>
</interactant>
<interactant intactId="EBI-5916454">
<id>A6NEM1</id>
<label>GOLGA6L9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-389564">
<id>Q00403</id>
</interactant>
<interactant intactId="EBI-355371">
<id>P20226</id>
<label>TBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-389564">
<id>Q00403</id>
</interactant>
<interactant intactId="EBI-357849">
<id>Q15025</id>
<label>TNIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-389564">
<id>Q00403</id>
</interactant>
<interactant intactId="EBI-637479">
<id>P46077</id>
<label>GRF4</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-389564">
<id>Q00403</id>
</interactant>
<interactant intactId="EBI-11712595">
<id>P87662</id>
<label>ICP0</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-389564">
<id>Q00403</id>
</interactant>
<interactant intactId="EBI-11702772">
<id>P17473</id>
<label>IE</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-389564">
<id>Q00403</id>
</interactant>
<interactant intactId="EBI-346797">
<id>P48281</id>
<label>Vdr</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="27">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="36">Chromosome</location>
</subcellularLocation>
<text evidence="36">Non-acetylated form colocalizes with DNA in the G0/1, S and G2 phases of the cell cycle, but not during mitosis (PubMed:24441171). Acetylated form colocalizes at transcriptionally silent mitotic chromatids during mitosis at metaphase, anaphase, and telophase phases of the cell cycle (PubMed:24441171).</text>
</comment>
<comment type="tissue specificity">
<text evidence="36">Expressed in the inner cell mass forming the embryoblast (PubMed:24441171). Not detected in cells from the outer thin layer trophoblast (at protein level) (PubMed:24441171).</text>
</comment>
<comment type="domain">
<text evidence="45 48 49 50">The TFIIB-type zinc-binding domain is necessary for the interaction and recruitment of RNA polymerase II to the core promoter, the formation of a fully competent pre-initiation complex (PIC) assembly and basal transcription initiation (PubMed:8515820, PubMed:8516311, PubMed:8516312, PubMed:8413225). The C-terminus is necessary and sufficient for interaction with the TATA box-bound TBP complex and for the formation of PIC (PubMed:8515820, PubMed:8516311, PubMed:8413225).</text>
</comment>
<comment type="PTM">
<text evidence="27 36">Acetylated (PubMed:24441171). Autoacetylated; autoacetylation at Lys-238 stimulates transcription activation (PubMed:12931194).</text>
</comment>
<comment type="similarity">
<text evidence="58">Belongs to the TFIIB family.</text>
</comment>
<dbReference type="EC" id="2.3.1.48" evidence="27"/>
<dbReference type="EMBL" id="X59268">
<property type="protein sequence ID" value="CAA41958.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M76766">
<property type="protein sequence ID" value="AAA61149.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK289822">
<property type="protein sequence ID" value="BAF82511.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB451296">
<property type="protein sequence ID" value="BAG70110.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL445991">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC020597">
<property type="protein sequence ID" value="AAH20597.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S44184">
<property type="protein sequence ID" value="AAB23144.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS715.1"/>
<dbReference type="PIR" id="S17654">
<property type="entry name" value="TWHU2B"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001505.1">
<property type="nucleotide sequence ID" value="NM_001514.5"/>
</dbReference>
<dbReference type="PDB" id="1C9B">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="A/E/I/M/Q=110-316"/>
</dbReference>
<dbReference type="PDB" id="1DL6">
<property type="method" value="NMR"/>
<property type="chains" value="A=2-59"/>
</dbReference>
<dbReference type="PDB" id="1RLY">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-60"/>
</dbReference>
<dbReference type="PDB" id="1RO4">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-60"/>
</dbReference>
<dbReference type="PDB" id="1TFB">
<property type="method" value="NMR"/>
<property type="chains" value="A=112-316"/>
</dbReference>
<dbReference type="PDB" id="1VOL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=113-316"/>
</dbReference>
<dbReference type="PDB" id="2PHG">
<property type="method" value="NMR"/>
<property type="chains" value="A=112-316"/>
</dbReference>
<dbReference type="PDB" id="5IY6">
<property type="method" value="EM"/>
<property type="resolution" value="7.20"/>
<property type="chains" value="M=1-316"/>
</dbReference>
<dbReference type="PDB" id="5IY7">
<property type="method" value="EM"/>
<property type="resolution" value="8.60"/>
<property type="chains" value="M=1-316"/>
</dbReference>
<dbReference type="PDB" id="5IY8">
<property type="method" value="EM"/>
<property type="resolution" value="7.90"/>
<property type="chains" value="M=1-316"/>
</dbReference>
<dbReference type="PDB" id="5IY9">
<property type="method" value="EM"/>
<property type="resolution" value="6.30"/>
<property type="chains" value="M=1-316"/>
</dbReference>
<dbReference type="PDB" id="5IYA">
<property type="method" value="EM"/>
<property type="resolution" value="5.40"/>
<property type="chains" value="M=1-316"/>
</dbReference>
<dbReference type="PDB" id="5IYB">
<property type="method" value="EM"/>
<property type="resolution" value="3.90"/>
<property type="chains" value="M=1-316"/>
</dbReference>
<dbReference type="PDB" id="5IYC">
<property type="method" value="EM"/>
<property type="resolution" value="3.90"/>
<property type="chains" value="M=1-316"/>
</dbReference>
<dbReference type="PDB" id="5IYD">
<property type="method" value="EM"/>
<property type="resolution" value="3.90"/>
<property type="chains" value="M=1-316"/>
</dbReference>
<dbReference type="PDB" id="5WH1">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.39"/>
<property type="chains" value="A/B/C/D=107-316"/>
</dbReference>
<dbReference type="PDB" id="6O9L">
<property type="method" value="EM"/>
<property type="resolution" value="7.20"/>
<property type="chains" value="M=1-316"/>
</dbReference>
<dbReference type="PDBsum" id="1C9B"/>
<dbReference type="PDBsum" id="1DL6"/>
<dbReference type="PDBsum" id="1RLY"/>
<dbReference type="PDBsum" id="1RO4"/>
<dbReference type="PDBsum" id="1TFB"/>
<dbReference type="PDBsum" id="1VOL"/>
<dbReference type="PDBsum" id="2PHG"/>
<dbReference type="PDBsum" id="5IY6"/>
<dbReference type="PDBsum" id="5IY7"/>
<dbReference type="PDBsum" id="5IY8"/>
<dbReference type="PDBsum" id="5IY9"/>
<dbReference type="PDBsum" id="5IYA"/>
<dbReference type="PDBsum" id="5IYB"/>
<dbReference type="PDBsum" id="5IYC"/>
<dbReference type="PDBsum" id="5IYD"/>
<dbReference type="PDBsum" id="5WH1"/>
<dbReference type="PDBsum" id="6O9L"/>
<dbReference type="SMR" id="Q00403"/>
<dbReference type="BioGRID" id="109214">
<property type="interactions" value="95"/>
</dbReference>
<dbReference type="CORUM" id="Q00403"/>
<dbReference type="DIP" id="DIP-1077N"/>
<dbReference type="IntAct" id="Q00403">
<property type="interactions" value="55"/>
</dbReference>
<dbReference type="MINT" id="Q00403"/>
<dbReference type="STRING" id="9606.ENSP00000359531"/>
<dbReference type="iPTMnet" id="Q00403"/>
<dbReference type="MetOSite" id="Q00403"/>
<dbReference type="PhosphoSitePlus" id="Q00403"/>
<dbReference type="BioMuta" id="GTF2B"/>
<dbReference type="DMDM" id="135629"/>
<dbReference type="EPD" id="Q00403"/>
<dbReference type="jPOST" id="Q00403"/>
<dbReference type="MassIVE" id="Q00403"/>
<dbReference type="MaxQB" id="Q00403"/>
<dbReference type="PaxDb" id="Q00403"/>
<dbReference type="PeptideAtlas" id="Q00403"/>
<dbReference type="PRIDE" id="Q00403"/>
<dbReference type="ProteomicsDB" id="57846"/>
<dbReference type="Antibodypedia" id="19819">
<property type="antibodies" value="417 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="2959"/>
<dbReference type="Ensembl" id="ENST00000370500">
<property type="protein sequence ID" value="ENSP00000359531"/>
<property type="gene ID" value="ENSG00000137947"/>
</dbReference>
<dbReference type="GeneID" id="2959"/>
<dbReference type="KEGG" id="hsa:2959"/>
<dbReference type="UCSC" id="uc001dmo.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2959"/>
<dbReference type="DisGeNET" id="2959"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000137947.11"/>
<dbReference type="GeneCards" id="GTF2B"/>
<dbReference type="HGNC" id="HGNC:4648">
<property type="gene designation" value="GTF2B"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000137947">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="189963">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q00403"/>
<dbReference type="OpenTargets" id="ENSG00000137947"/>
<dbReference type="PharmGKB" id="PA29035"/>
<dbReference type="eggNOG" id="KOG1597">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000006671"/>
<dbReference type="InParanoid" id="Q00403"/>
<dbReference type="KO" id="K03124"/>
<dbReference type="OMA" id="DQRMKRS"/>
<dbReference type="OrthoDB" id="729732at2759"/>
<dbReference type="PhylomeDB" id="Q00403"/>
<dbReference type="TreeFam" id="TF105953"/>
<dbReference type="PathwayCommons" id="Q00403"/>
<dbReference type="Reactome" id="R-HSA-167161">
<property type="pathway name" value="HIV Transcription Initiation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167162">
<property type="pathway name" value="RNA Polymerase II HIV Promoter Escape"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167172">
<property type="pathway name" value="Transcription of the HIV genome"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-674695">
<property type="pathway name" value="RNA Polymerase II Pre-transcription Events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6807505">
<property type="pathway name" value="RNA polymerase II transcribes snRNA genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-73776">
<property type="pathway name" value="RNA Polymerase II Promoter Escape"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-73779">
<property type="pathway name" value="RNA Polymerase II Transcription Pre-Initiation And Promoter Opening"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-75953">
<property type="pathway name" value="RNA Polymerase II Transcription Initiation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-76042">
<property type="pathway name" value="RNA Polymerase II Transcription Initiation And Promoter Clearance"/>
</dbReference>
<dbReference type="SIGNOR" id="Q00403"/>
<dbReference type="BioGRID-ORCS" id="2959">
<property type="hits" value="763 hits in 878 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="GTF2B">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q00403"/>
<dbReference type="GeneWiki" id="Transcription_factor_II_B"/>
<dbReference type="GenomeRNAi" id="2959"/>
<dbReference type="Pharos" id="Q00403">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q00403"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="Q00403">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000137947">
<property type="expression patterns" value="Expressed in oocyte and 237 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q00403">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q00403">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005694">
<property type="term" value="C:chromosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016604">
<property type="term" value="C:nuclear body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032993">
<property type="term" value="C:protein-DNA complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090575">
<property type="term" value="C:RNA polymerase II transcription regulator complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005669">
<property type="term" value="C:transcription factor TFIID complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097550">
<property type="term" value="C:transcription preinitiation complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0016407">
<property type="term" value="F:acetyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001046">
<property type="term" value="F:core promoter sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004402">
<property type="term" value="F:histone acetyltransferase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:1990841">
<property type="term" value="F:promoter-specific chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000993">
<property type="term" value="F:RNA polymerase II complex binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001139">
<property type="term" value="F:RNA polymerase II complex recruiting activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000979">
<property type="term" value="F:RNA polymerase II core promoter sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016251">
<property type="term" value="F:RNA polymerase II general transcription initiation factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0017025">
<property type="term" value="F:TBP-class protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0046966">
<property type="term" value="F:thyroid hormone receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006352">
<property type="term" value="P:DNA-templated transcription, initiation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043923">
<property type="term" value="P:positive regulation by host of viral transcription"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904798">
<property type="term" value="P:positive regulation of core promoter binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0060261">
<property type="term" value="P:positive regulation of transcription initiation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050434">
<property type="term" value="P:positive regulation of viral transcription"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0006473">
<property type="term" value="P:protein acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990114">
<property type="term" value="P:RNA polymerase II core complex assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051123">
<property type="term" value="P:RNA polymerase II preinitiation complex assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042795">
<property type="term" value="P:snRNA transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006366">
<property type="term" value="P:transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006367">
<property type="term" value="P:transcription initiation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001174">
<property type="term" value="P:transcriptional start site selection at RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd00043">
<property type="entry name" value="CYCLIN"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="IDEAL" id="IID00314"/>
<dbReference type="InterPro" id="IPR013763">
<property type="entry name" value="Cyclin-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR036915">
<property type="entry name" value="Cyclin-like_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000812">
<property type="entry name" value="TFIIB"/>
</dbReference>
<dbReference type="InterPro" id="IPR023486">
<property type="entry name" value="TFIIB_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR013150">
<property type="entry name" value="TFIIB_cyclin"/>
</dbReference>
<dbReference type="InterPro" id="IPR013137">
<property type="entry name" value="Znf_TFIIB"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11618">
<property type="entry name" value="PTHR11618"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08271">
<property type="entry name" value="TF_Zn_Ribbon"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00382">
<property type="entry name" value="TFIIB"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PRINTS" id="PR00685">
<property type="entry name" value="TIFACTORIIB"/>
</dbReference>
<dbReference type="SMART" id="SM00385">
<property type="entry name" value="CYCLIN"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47954">
<property type="entry name" value="SSF47954"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00782">
<property type="entry name" value="TFIIB"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS51134">
<property type="entry name" value="ZF_TFIIB"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0012">Acyltransferase</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Transcription initiation factor IIB" id="PRO_0000119293">
<location>
<begin position="1"/>
<end position="316"/>
</location>
</feature>
<feature type="repeat" description="1">
<location>
<begin position="124"/>
<end position="200"/>
</location>
</feature>
<feature type="repeat" description="2">
<location>
<begin position="218"/>
<end position="294"/>
</location>
</feature>
<feature type="zinc finger region" description="TFIIB-type" evidence="21">
<location>
<begin position="11"/>
<end position="42"/>
</location>
</feature>
<feature type="region of interest" description="Core promoter DNA-binding" evidence="24">
<location>
<begin position="189"/>
<end position="193"/>
</location>
</feature>
<feature type="region of interest" description="Necessary for TATA box-bound TBP complex formation" evidence="48 49">
<location>
<begin position="244"/>
<end position="316"/>
</location>
</feature>
<feature type="region of interest" description="Core promoter DNA-binding" evidence="42">
<location>
<begin position="249"/>
<end position="252"/>
</location>
</feature>
<feature type="region of interest" description="Core promoter DNA-binding" evidence="24 42">
<location>
<begin position="283"/>
<end position="286"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="2 3 26 28">
<location>
<position position="15"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc; via tele nitrogen" evidence="2 3 26 28">
<location>
<position position="18"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="2 3 26 28">
<location>
<position position="34"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="2 3 26 28">
<location>
<position position="37"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="19">
<location>
<position position="70"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17 18 19">
<location>
<position position="76"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="19">
<location>
<position position="92"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by autocatalysis" evidence="27">
<location>
<position position="238"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1804499." id="VAR_011977">
<original>P</original>
<variation>S</variation>
<location>
<position position="19"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal cancer sample; somatic mutation; dbSNP:rs144944840." id="VAR_035722" evidence="32">
<original>R</original>
<variation>Q</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not inhibit interaction with TBP. Inhibits the recruitment of RNA polymerase II into the initiation complex." evidence="50">
<original>C</original>
<variation>S</variation>
<location>
<position position="37"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partial loss of HIV-1 Vpr binding." evidence="23">
<original>EWRTFS</original>
<variation>AWRTFA</variation>
<location>
<begin position="51"/>
<end position="56"/>
</location>
</feature>
<feature type="mutagenesis site" description="Defects in transcription start site selection. Supports a level of transcription equivalent to wild-type." evidence="22">
<original>E</original>
<variation>R</variation>
<variation>A</variation>
<variation>D</variation>
<location>
<position position="51"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partial loss of HIV-1 Vpr binding." evidence="23">
<original>W</original>
<variation>A</variation>
<location>
<position position="52"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partial loss of HIV-1 Vpr binding." evidence="23">
<original>RT</original>
<variation>AA</variation>
<location>
<begin position="53"/>
<end position="54"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partial loss of HIV-1 Vpr binding." evidence="23">
<original>F</original>
<variation>A</variation>
<location>
<position position="55"/>
</location>
</feature>
<feature type="mutagenesis site" description="Defects in transcription start site selection. Supports a level of transcription equivalent to wild-type." evidence="22">
<original>R</original>
<variation>A</variation>
<variation>E</variation>
<variation>K</variation>
<location>
<position position="66"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases BREd-dependent pre-initiation complex formation." evidence="31">
<original>G</original>
<variation>Q</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces interaction with SSU72; when associated with E-193 or E-200. Inhibits interaction with VP16; when associated with E-193. Inhibits RNA pol II transcription activation induced by VP16 but does not affect basal transcription; when associated with E-193." evidence="38 47">
<original>R</original>
<variation>E</variation>
<location>
<position position="185"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces interaction with VP16; when associated with L-189." evidence="47">
<original>R</original>
<variation>L</variation>
<location>
<position position="185"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with SSU72; when associated with E-193. Reduces interaction with SSU72; when associated with E-200. Inhibits interaction with VP16; when associated with E-200. Inhibits RNA pol II transcription activation induced by VP16 but does not affect basal transcription; when associated with E-200." evidence="38 47">
<original>K</original>
<variation>E</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces interaction with VP16; when associated with L-185." evidence="47">
<original>K</original>
<variation>L</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with SSU72; when associated with E-185 or E-189. Inhibits interaction with VP16; when associated with E-185. Inhibits RNA pol II transcription activation induced by VP16 but does not affect basal transcription; when associated with E-185." evidence="38 47">
<original>R</original>
<variation>E</variation>
<location>
<position position="193"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces interaction with VP16; when associated with L-200." evidence="47">
<original>K</original>
<variation>L</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces the formation of the TATA box-bound TBP ternary complex." evidence="38">
<original>KALETSVDL</original>
<variation>GSGS</variation>
<location>
<begin position="200"/>
<end position="208"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces interaction with SSU72; when associated with E-185 or E-189. Inhibits interaction with VP16; when associated with E-189. Inhibits RNA pol II transcription activation induced by VP16 but does not affect basal transcription; when associated with E-189." evidence="38 47">
<original>K</original>
<variation>E</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces the formation of the TATA box-bound TBP ternary complex." evidence="38">
<original>K</original>
<variation>KGSGS</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces interaction with VP16; when associated with L-196." evidence="47">
<original>K</original>
<variation>L</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not inhibit the formation of the TATA box-bound TBP ternary complex." evidence="38">
<original>L</original>
<variation>LGSGS</variation>
<location>
<position position="208"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes autoacetylation, represses transcription activity, does not inhibit its association with chromatin to promoter-specific regions and decreases the association of GTF2F1 with chromatin to promoter-specific regions." evidence="27">
<original>K</original>
<variation>A</variation>
<location>
<position position="238"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with TBP." evidence="50">
<original>G</original>
<variation>V</variation>
<location>
<position position="247"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces DNA-binding." evidence="54">
<original>V</original>
<variation>A</variation>
<location>
<position position="283"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces DNA-binding." evidence="54">
<original>R</original>
<variation>A</variation>
<location>
<position position="286"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with RNA polymerase II; when associated with E-290 and E-295." evidence="46">
<original>R</original>
<variation>E</variation>
<location>
<position position="286"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with RNA polymerase II; when associated with E-286 and E-295." evidence="46">
<original>R</original>
<variation>E</variation>
<location>
<position position="290"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with RNA polymerase II; when associated with E-286 and E-290." evidence="46">
<original>R</original>
<variation>E</variation>
<location>
<position position="295"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="4"/>
<end position="6"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="18"/>
<end position="21"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="24"/>
<end position="26"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="27"/>
<end position="29"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="35"/>
<end position="37"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="111"/>
<end position="113"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="114"/>
<end position="127"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="132"/>
<end position="148"/>
</location>
</feature>
<feature type="helix" evidence="16">
<location>
<begin position="149"/>
<end position="151"/>
</location>
</feature>
<feature type="strand" evidence="16">
<location>
<begin position="152"/>
<end position="154"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="156"/>
<end position="170"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="177"/>
<end position="182"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="184"/>
<end position="186"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="188"/>
<end position="201"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="212"/>
<end position="221"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="226"/>
<end position="241"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="250"/>
<end position="263"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="265"/>
<end position="267"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="271"/>
<end position="278"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="282"/>
<end position="292"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="293"/>
<end position="295"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="296"/>
<end position="299"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="310"/>
<end position="312"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1C9B"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1DL6"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1RLY"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1RO4"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1TFB"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1VOL"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2PHG"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5IY6"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5IY7"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5IY8"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5IY9"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5IYA"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5IYB"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5IYC"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5IYD"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5WH1"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P62915"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00469"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10318856"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10359081"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10619841"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11005381"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11045620"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12931194"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14641108"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1517211"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15654739"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16230532"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1876184"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1946368"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2247058"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24441171"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27193682"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29158257"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3029109"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3818643"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7601352"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7675079"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7983760"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8392607"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8413225"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8504927"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8515819"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8515820"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8516311"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8516312"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8566795"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8662660"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8800208"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9420329"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1517211"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1876184"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1946368"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000305"/>
<sequence length="316" mass="34833" checksum="9CC7E102526C2722" modified="1992-12-01" version="1">MASTSRLDALPRVTCPNHPDAILVEDYRAGDMICPECGLVVGDRVIDVGSEWRTFSNDKATKDPSRVGDSQNPLLSDGDLSTMIGKGTGAASFDEFGNSKYQNRRTMSSSDRAMMNAFKEITTMADRINLPRNIVDRTNNLFKQVYEQKSLKGRANDAIASACLYIACRQEGVPRTFKEICAVSRISKKEIGRCFKLILKALETSVDLITTGDFMSRFCSNLCLPKQVQMAATHIARKAVELDLVPGRSPISVAAAAIYMASQASAEKRTQKEIGDIAGVADVTIRQSYRLIYPRAPDLFPTDFKFDTPVDKLPQL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

